News
Real-time feed summarized and tagged.
- Reuters6/7/2026, 6:33:43 PMBoehringer-Zealand's obesity drug shows promise in cutting visceral, liver fat - Reuters
Boehringer Ingelheim and Zealand Pharma's obesity drug has shown promising results in reducing visceral and liver fat, according to Reuters. The data suggests potential efficacy beyond weight loss, targeting metabolically harmful fat deposits. No further trial phase or regulatory filing details are provided in the headline.
Yesterday markets, in your inbox.
Top-discussed tickers and the AI sentiment we read. Not advice.